Evidence map›Paper›PMID 40456795›Full record

ArticleScientific reports2025

Isolation and characterization of Chitosan from shrimp shell waste and the sustainable preparation of salicylic acid-loaded Chitosan nanoparticles for antibiofilm applications.

Habiba A Ahmed, Yousra A El-Maradny, Manal A Shalaby, Hany El-Menshawy, Abeer E Abd El-Wahab

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. A chitosan/rGO/FeRSC advances · 2026
    Article
  4. Article
  5. Article
  6. Nano-encapsulatedRSC advances · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Habiba A AhmedPlant Biochemistry Department, National Research Centre, Dokki, 12622, Giza, Egypt.
Yousra A El-MaradnyMedical Biotechnology Department, Institute of Genetic Engineering and Biotechnology, City of Scientific Research and Technological Applications (SRTA-City), New Borg EL-Arab, 21934, Alexandria, Egypt. Hiph.ymaradny@alexu.edu.eg.ORCID http://orcid.org/0000-0001-9501-8059
Manal A ShalabyMedical Biotechnology Department, Institute of Genetic Engineering and Biotechnology, City of Scientific Research and Technological Applications (SRTA-City), New Borg EL-Arab, 21934, Alexandria, Egypt.
Hany El-MenshawySummerMoon for Food Industries, Alexandria, Egypt.
Abeer E Abd El-WahabMedical Biotechnology Department, Institute of Genetic Engineering and Biotechnology, City of Scientific Research and Technological Applications (SRTA-City), New Borg EL-Arab, 21934, Alexandria, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial biofilms present a significant global health challenge, as they are associated with severe chronic infections and the emergence of antibiotic resistance. Currently, only a limited number of clinically available drugs effectively target microbial biofilms. This underscores the urgent need for the development of new sustainable therapeutic strategies to address biofilm-associated infections. Developing a sustainable and biodegradable preparation for eradicating microbial biofilms is critically important. In this study, chitosan was extracted from shrimp shell waste and utilized to prepare salicylic acid-loaded chitosan nanoparticles (NPs) using various synthesis methods. The particle size of the prepared nanoparticles ranged from 287.4 to 226.3 nm, with zeta potential values between + 36.6 and + 41.3 mV, indicating good stability. The nanoparticles demonstrated safety, with half maximal inhibitory concentration (IC

Indexed as

BiofilmsChitosanNanoparticlesSalicylic AcidAnimalsAnti-Bacterial AgentsCandida albicansEscherichia coliMicrobial Sensitivity TestsParticle SizeStaphylococcus aureusAnti-Bacterial AgentsChitosanSalicylic AcidAnd biofilmEco-friendlyMicrobial resistanceNano formulationPolymerSustainability

Identifiers

PMID40456795
PMCPMC12130262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.